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a  b  s  t  r  a  c  t
Nanoparticles  (NPs)  of zinc  oxide  (ZnO)  and  titanium  dioxide  (TiO2) are receiving  increas-
ing attention  due  to  their  widespread  applications.  The  aim  of this  study  was  to  evaluate
the  toxic  effect  of ZnO  and  TiO2 NPs at different  concentrations  (50,  100,  250 and  500  ppm)
and  compare  them  with  their  respective  salts  using  a battery  of  cytotoxicity,  and geno-
toxicity  parameters.  To  evaluate  cytotoxicity,  we  have  used  human  erythrocytes  and  for
genotoxic  studies  human  lymphocytes  have  been  used  as  in  vitro model  species.  Concen-
tration  dependent  hemolytic  activity  to RBC’s  was obtained  for both  NPs.  ZnO and  TiO2
NPs  resulted  in  65.2%  and  52.5%  hemolysis  at 250 ppm  respectively  indicating  that  both  are
cytotoxic  to  human  RBCs.  Antioxidant  enzymes  assays  were  also  carried  out  in  their  respec-
tive  hemolysates.  Both  nanoparticles  were  found  to  generate  reactive  oxygen  species  (ROS)
concomitant  with  depletion  of  glutathione  and  GST  levels  and  increased  SOD,  CAT  and  lipid
peroxidation  in dose  dependent  manner.  ZnO  and  TiO2 NPs  exerted  roughly  equal  oxidative
stress in  terms  of  aforementioned  stress  markers.  Genotoxic  potential  of  both  the  NPs  was
investigated  by in  vitro  alkaline  comet  assay.  DNA  damage  induced  by the  NPs  was  concen-
tration  dependent  and  was  signiﬁcantly  greater  than  their  ionic  forms  at  250 and  500  ppm
concentrations.  Moreover,  the nanoparticles  of ZnO  were  signiﬁcantly  more  genotoxic  than
those  of  TiO2 at higher  concentrations.  The  toxicity  of  these  NPs  is  due to  the  generation  of
ROS  thereby  causing  oxidative  stress.
©  2015  The  Authors.  Published  by  Elsevier  Ireland  Ltd. This  is  an  open  access  article  under
Y-NC-Nthe  CC  B
. Introduction
Nanotechnology has gained a great deal of public
nterest due to increasing applications of nanomaterials
1–100 nm)  in many areas of human endeavors such as
ndustry, agriculture, business, medicine, public health etc.
owever, several studies conducted during the last few
ears indicate that nanoparticles (NPs) may  interfere with
ellular system by the interaction with proteins, DNA,
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lipids, membranes, organelles and biological ﬂuids [1,2].
Because of their extremely small size and large surface
area to volume ratio, they can easily cross the biologi-
cal cells and membranes. Once inside the body, they can
enter the bloodstream and hence reach different organs [3].
Although the mechanisms underlying the NPs toxicity are
not yet clear, it has been suggested that oxidative stress and
lipid peroxidation play an important role in DNA damage,
cell membrane disruption and cell death [4–6].According to U.S National Nanotechnology Initiative
titanium dioxide nanoparticles (TiO2 NPs) are one of the
largest manufactured NPs in the world. They are used in
variety of applications as paints, printing ink, rubber, paper,
is is an open access article under the CC BY-NC-ND license
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cosmetics, pharmaceuticals, sunscreens, car materials,
implanted biomaterials and decomposing organic matters
in waste water [7–9]. Zinc oxide nanoparticles (ZnO NPs)
are widely used as nanosensors [10], UV-absorbers [11],
and catalysts [12]. Zinc oxide (ZnO) nanoparticles are also
employed in cosmetics and modern sunscreens, in coatings
(UV protection) and electronic devices [13].
Due to the increasing common applications of ZnO and
TiO2 NPs in the market, it is essential to know the harm-
ful effects caused by them on the health of individuals as
well as the environment. The aim of the present study
was to evaluate the toxic effects of ZnO and TiO2 NPs in
humans compared with their respective salts using a bat-
tery of cytotoxic, and genotoxic parameters so that their
use is limited or else used in safe doses. Also, present study
has demonstrated for the ﬁrst time the in vitro generation
of ROS by ZnO and TiO2 NPs.
2. Materials and methods
Ethical statement
5 ml  each of fresh human blood (self donor) was taken
for both experiments i.e. hemolysis assay and comet assay.
According to Indian Council for Medical Research, New
Delhi, India, Chapter-II, page no.11–12, the ethical approval
for this research was not deemed to be necessary. Accord-
ing to this guideline, proposals which present less than
minimal risks are exempted from the ethical review pro-
cess.
2.1. Chemicals and materials
5,5′-Dithiobis-(2-nitrobenzoic acid)-DTNB, ethylene
diamine tetra acetic acid (EDTA), horse radish peroxi-
dase (HRP), glutathione reduced, pyrogallol and heparin
were obtained from Sisco Research Laboratories (SRL),
India. Histopaque-1077, RPMI-1640 medium, low melting
agarose and thiobarbituric acid (TBA) were purchased
from Sigma Chemicals Co, USA. Trichloro acetic acid (TCA)
was obtained from Qualigens Fine Chemicals, India while
ethidium bromide (EtBr) from Hi Media, India Ltd. All
other chemicals were of highest analytical grade available.
2.2. Preparation and characterization of nanoparticles
2.2.1. Preparation of ZnO nanoparticles
In a typical synthesis method, Zinc acetate [(Zn
(CH3COO)2·2H2O] and citric acid (1:1 molar ratio) were
dissolved in deionised water. The solution was stirred at
100 ◦C for 1 h (hour) till the formation of gel. The gel was
burned at 200 ◦C and further annealed at 450 ◦C for 1 h to
obtain the crystalline ZnO NPs [14].
2.2.2. Preparation of TiO2 nanoparticles
TiO2 NPs were synthesized by hydrolyzing titanium iso-
propoxide [Ti{OCH(CH3)2}4] in a mixture of ethanol and
water. The so obtained gel was dried at 80◦C for 4 h. Finally,
the white powder was calcined at 500 ◦C [15].orts 2 (2015) 765–774
2.2.3. Characterization of nanoparticles
The ZnO and TiO2 NPs prepared as above were
characterized by X-ray diffraction (XRD) and trans-
mission electron microscopy (TEM). The XRD pattern
was  obtained using X-ray diffractometer (Rigaku, Japan-
Miniﬂex-II) using scan speed 4 steps/s and angle range
(20–80◦). The morphologies of both the NPs were examined
by transmission electron microscopy (TEM-JEOL-2100F).
Fourier transform infrared (FTIR) spectra of the samples
were recorded using FTIR-Perkin Elmer instrument, USA
(Spectrum-II, wave no. 4000–400).
2.3. Stock sample preparation
The ZnO and TiO2 nanoparticles were suspended in dis-
tilled water and dispersed by ultrasonic vibrations (130 W,
20 kHz) for 20 min  (minutes) for all experimental works.
2.4. Toxicological tests
2.4.1. Hemolysis
2.4.1.1. Isolation of erythrocytes from human blood. Hep-
arinized fresh human blood was  taken from young, healthy,
non-smoking individual (self donor). It was  centrifuged at
1500 rpm for 10 min  at 4 ◦C in a clinical centrifuge and
the plasma and buffy coat were removed by aspiration.
The erythrocyte pellet was washed thrice with phosphate
buffered saline (PBS) (0.01 M sodium phosphate buffer,
0.9% NaCl, pH 7.2) and resuspended in PBS to give a 5%
hematocrit [16].
2.4.1.2. Treatment of erythrocytes with samples and prepara-
tion of lysates. Erythrocytes were incubated with different
concentrations (50 ppm, 100 ppm, 250 ppm, 500 ppm) of
both the NPs and their respective salts separately for 1 h
at 37 ◦C. The samples were centrifuged at 2500 rpm for
10 min  at 4 ◦C. The pellets so obtained were washed thrice
with PBS and erythrocytes were lysed with 10 volumes of
distilled water at 4 ◦C for 2 h. The hemolysates were cen-
trifuged at 3000 rpm for 10 min  at 4 ◦C and the supernatants
were quickly frozen in aliquots and later used for biochem-
ical estimations. Untreated erythrocytes were completely
lysed with distilled water and used as reference.
2.4.1.3. Determination of total protein concentration. Total
protein content in the hemolysates was  estimated by
Folin’s reagent using bovine serum albumin as standard
[17].
2.4.2. Assays of enzymatic and non-enzymatic
antioxidants
2.4.2.1. Superoxide dismutase (SOD). SOD activity in the
hemolysates was assayed by measuring its ability to inhibit
the auto oxidation of pyrogallol according to the method
of Marklund and Marklund [18]. To 50 l of hemolysate,
2.85 ml  of tris succinate buffer (0.05 M,  pH 8.2) was  added
and the reaction was  started by adding 100 l of 8.0 mM
pyrogallol. The change in absorbance was recorded at an
interval of 30 s (seconds) for 3 min  at 412 nm.  A reference
set containing 50 l distilled water instead of hemolysate,
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as also run simultaneously. The activity was reported in
erms of U/mg protein.
.4.2.2. Catalase (CAT). Catalase activity was measured
ssentially following the method of Aebi [19]. 3 ml  reaction
ixture contained 1.9 ml  of 0.05 M potassium phosphate
uffer (pH-7.4), 1 ml  of 30 mM H2O2 and 100 l of test sam-
le’s hemolysate and absorbance at 240 nm was recorded
t an interval of 30 s for 3 min. Enzyme activity was  cal-
ulated using the molar extinction coefﬁcient of H2O2 as
36 mol  l−1 cm−1 at 240 nm and reported in U/mg protein.
.4.2.3. Lipid peroxidation (LPO). The extent of membrane
ipid peroxidation was determined from malondialdehyde
MDA, an end product of LPO) content by the method of
euge and Aust [20]. 1.0 ml  of hemolysate was mixed with
.0 ml  of TBA–TCA–HCl reagent and the mixture was  heated
n boiling water bath for 15 min. After cooling to room
emperature, the precipitate was removed by centrifuga-
ion at 4000 rpm for 10 min  and absorbance of supernatant
as recorded at 535 nm against a blank that contained
ll reagents except hemolysate. The MDA  concentration
as calculated using a molar extinction coefﬁcient of
.56 × 105 M−1 cm−1 and reported in nmole/mg protein.
.4.2.4. Glutathione-S-transferase (GST). The activity of GST
as assayed by the method as described by Habig et al.
21], using CDNB (1-chloro-2,4-dinitrobenzene) as sub-
trate and measuring the amount of CDNB–GSH conjugate
ormed. Absorbance at 340 nm was recorded at an interval
f 30 s for 3 min.
.4.2.5. Glutathione (GSH) estimation. GSH levels were esti-
ated by the method of Jollow et al. [22] using the classical
TNB reagent. 500 l of 4% sulphosalicylic acid was added
o 100 l of hemolysate. It was left for incubation at 4 ◦C
or 1 h. Then the mixture was centrifuged at 12,000 × g for
5 min  at 4 ◦C and the supernatant was taken out. 0.4 ml
f supernatant was mixed with 2.2 ml  of potassium phos-
hate buffer (0.1 M,  pH 7.4) and 0.4 ml  DTNB (4 mg/ml).
ellow color developed by the reaction of GSH with DTNB
as read at 412 nm.  The concentration is reported in terms
f nmole/mg protein.
.4.3. Estimation of ROS generation in the test samples
.4.3.1. Hydrogen peroxide. The amount of H2O2 in the test
ater sample was estimated by the horse radish perox-
dase (HRPO) mediated oxidation of phenol red by H2O2
23]. The reaction mixtures containing 2.8 ml  phenol red
0.28 mM phenol red, 20 U ml−1 HRPO, 5.5 mM dextrose,
0 mM potassium phosphate buffer, pH 7.0), 100 l of
aOH (1N) and different volumes of test samples (10 l,
0 l, 50 l, 100 l) were incubated at 37 ◦C for 10 min  in
ark. At the completion of incubation, the reaction mixture
as centrifuged for 5 min  at 2500 rpm at 4 ◦C. Absorbance
as taken at 610 nm..4.3.2. Hydroxyl radicals. The estimation of •OH radical
as carried out by the method of Richmond et al. [24]. To
ifferent concentrations of test samples, 150 l of Tris–HCl
uffer (0.01 M,  pH 7.5) and 300 l of calf thymus DNArts 2 (2015) 765–774 767
(3.0 mM)  were added, and the mixture was incubated for
1 h at 37 ◦C. This is followed by the addition of 1.2 ml  of 28%
TCA, to stop the reaction. After that 1.2 ml  of 1% TBA was
added and test tubes were boiled for 15 min. After cool-
ing the test tubes to room temperature, absorbance was
recorded at 532 nm.
2.4.3.3. Super-oxide radical. The estimation of O2•− was
done by NBT–O2•− determination method of Nakayama
et al. [25]. The reaction mixture contained 300 l of sodium
phosphate buffer (100 mM,  pH-8), 100 l of NBT (1 mM),
300 l of triton-X-100 (0.6%), 2.2 ml  of D.W., and differ-
ent volumes of test samples (10 l, 20 l, 50 l, 100 l).
Absorbance was  taken at 560 nm.
2.4.4. Comet assay (single cell gel electrophoresis)
2.4.4.1. Isolation of lymphocytes. Heparinized blood sam-
ple was  obtained from a single healthy volunteer (self
donor) and diluted suitably in saline in 1:1 ratio. 1/3 of
the total volume, histopaque 1077 (Sigma, USA; density –
1.077) was  taken in a centrifuge tube and the diluted blood
was added along the sides of the tube over the histopaque.
The blood was  centrifuged at 2400 rpm for 20 min. The
cloudy layer seen at the junction was  pipetted out very
carefully and the lymphocytes were diluted with saline in
1:1 ratio. 100 of diluted lymphocytes were taken in each
microfuge tube.
2.4.4.2. Experimental procedure. Comet assay was per-
formed under alkaline conditions according to the
procedure of Singh et al. [26] with slight modiﬁcations.
Fully frosted microscopic slides pre-coated with 1.0% nor-
mal  melting agarose. Diluted lymphocytes were then
mixed properly with equal volume of 2.0% low melting
agarose and half of the mixture was pipetted over the ﬁrst
layer. The slides were covered immediately by cover slips
and placed on ice for 15 min  to solidify. Immediately after
removing the cover slips, within 20 min  cells were treated
with increasing concentrations of samples (0–500 ppm) for
1 h at 4 ◦C. Lysis was  done in cold lysis solution containing
2.5 M NaCl, 100 mM EDTA, 10 mM Tris (pH 10) and 1% Tri-
ton X-100 (added just prior to use) for 1 h at 4 ◦C followed
by unwinding of DNA for 30 min  in alkaline electrophoretic
solution containing 300 mM NaOH, 1 mM EDTA, pH 13 (at
4 ◦C, 300 mA current). After electrophoresis, DNA was neu-
tralized in neutralizing solution (0.4 M Tris, pH 7.5). The
slides were stained with 75 l ethidium bromide (EtBr,
20 g/ml), washed with distilled water, covered with cover
slips and placed in a humidiﬁed chamber.
2.4.4.3. Visualization of slides and scoring. Slides were visu-
alized using an image analysis system (Komet 5.5; Kinetic
Imaging, Liverpool, UK) attached to an Olympus (CX41) ﬂu-
orescent microscope (Olympus Optical Co., Tokyo, Japan)
and a COHU 4910-integrated CC camera (equipped with
510–560 nm excitation and 590 nm barrier ﬁlters) (COHU,
San Diego, USA). Images from 50 cells (25 from each repli-
cate slide) were analyzed. Tail length (migration of DNA
from the nucleus in m)  was chosen as the parameter to
assess DNA damage.
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2.5. Statistical evaluation
Data was expressed as mean ± S.D. of three independent
experiments and statistical analysis was performed by one
way ANOVA test. Differences among control and treated
groups were determined using student’s t-test. p values
of ≤0.05 were considered statistically signiﬁcant. All com-
parisons were made with ionic forms (serving as positive
control) and untreated cells (serving as negative control).
3. Results
3.1. Nanoparticles characterization
3.1.1. X-ray diffraction
Fig. 1(a) shows X-ray diffraction pattern of zinc oxide
nanoparticles. Highly intense peaks observed in the XRD
pattern indicated that ZnO NPs were well crystalline. The
peaks were obtained in the samples at 2 = 31.2◦, 33.9◦,
35.5◦, 46.9◦, 56.0◦, 62.0◦, 67.0◦, hence no diffraction peaks
of other impurities were detected, which conﬁrmed that
the prepared sample was pure ZnO NPs. Similar results
were also reported by others [27–30]. The crystal size of
the ZnO NPs calculated from the XRD spectra was found to
be 17.1 nm.
(b)
(a)
Fig. 1. (a) XRD pattern of ZnO nanoparticles. (b) XRD pattern of TiO2
nanoparticles.Fig. 2. (a) FTIR spectra of ZnO nanoparticles. (b) FTIR spectra of TiO2
nanoparticles.
Fig. 1(b) shows the X-ray diffraction (XRD) pattern of
TiO2 NPs. Peaks at 25.8◦, 32.9◦, 37.0◦, 50.7◦, 53.0◦, 61.0◦,
63.0◦, 69.0◦, 77.1◦ were observed which conﬁrms the for-
mation of mixed phase of TiO2 NPs (anatase and rutile).
Similar results were also obtained by Chaudhary et al. [31],
Ba-Abbad et al. [32] and Hema et al. [33]. The appear-
ance of sharp diffraction patterns indicates the small size,
high purity and crystallinity of the synthesized sample [34].
Diffraction pattern corresponding to impurities were found
to be absent. In the present study, the size of the TiO2 NPs
crystals calculated from the XRD spectra was  found to be
17.8 nm.
3.1.2. Fourier transmission infrared spectroscopy
Fig. 2(a) shows FTIR spectra of the ZnO NPs. FTIR stud-
ies were carried out to ascertain the purity and nature of
these nanoparticles. Metal oxides generally give absorption
bands in ﬁngerprint region i.e. below 1000 cm−1 arising
from inter-atomic vibrations. The peaks observed at 3372
and 3178 cm−1 are due to O H stretching [35]. Peaks
at 1656 cm−1 and 1427 cm−1 correspond to C C stretch
and C C stretching respectively. The peaks at 1027 and
545 cm−1 are the characteristic absorption peaks of Zn–O
bond and also authenticates the presence of ZnO [35,36].
FTIR spectrum of the TiO2 NPs is shown in Fig. 2(b). Peaks
at 3397 cm−1 correspond to stretching vibrations of O H
bond [33]. Peaks observed at 1560 and 1403 are attributed
to C C stretching. Sharp peaks at 1223 and 1056 cm−1 are
M. Khan et al. / Toxicology Reports 2 (2015) 765–774 769
rticles. (b) TEM image of TiO2 nanoparticles.
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Fig. 5. Increasing activity of SOD in hemolysates prepared before and
ide dismutase (SOD) and catalase (CAT) respectively inFig. 3. (a) TEM image of ZnO nanopa
ue to C O stretching [33]. Peaks observed at 846 cm−1 and
53 cm−1 indicated Ti O vibrations [32].
.1.3. Transmission electron microscopy
Fig. 3(a) shows the TEM image of ZnO NPs. Rod shaped
nO NPs were observed in TEM images with average size
n the range of 47.8–52.5 nm.  The particle size and shape
f TiO2 nanoparticles were determined by TEM and shown
n Fig. 3(b). The TEM image shows that the TiO2 NPs are
oughly spherical with an average size in the range of
6.0–60.9 nm.
.2. Toxicity tests
.2.1. Hemolysis
Fig. 4 shows the plot of percent hemolysis with increas-
ng concentrations of both NPs and their respective salts
n the range of 50–500 ppm. ZnO and TiO2 NPs showed
5.2% and 52.5% hemolysis respectively at 250 ppm (Fig. 4).
tatistical analysis was performed between the individual
Ps and their respective ionic forms. Based on ANOVA test,
e found statistically insigniﬁcant difference between the
ytotoxicity of NPs and their respective ions.
ig. 4. Increasing rates of hemolysis in human erythrocytes upon incu-
ation with increasing concentrations of ZnO and TiO2 nanoparticles and
heir ionic counterparts. Data represent mean ± S.D. of three individual
xperiments, p-value ≤0.05.after treatment with increasing concentrations of ZnO and TiO2 nanopar-
ticles along with their respective salts. Data represent mean ± S.D. of three
individual experiments, p-value ≤0.05.
3.2.2. Oxidative stress markers
Figs. 5 and 6 present the activity proﬁles of superox-the hemolysates upon treatment with nanoparticles as
well as with their respective ionic forms. At 500 ppm, ZnO
NPs showed 77% more increase with respect to untreated
Fig. 6. Activity proﬁle of CAT in hemolysates prepared before and after
incubation with increasing concentrations of ZnO and TiO2 nanoparti-
cles and their respective ions. CAT activity was increased with respect
to  control, signiﬁcant increase at 250 and 500 ppm. All values represent
mean ± S.D. of three individual experiments (n = 3), p-value ≤0.05.
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Fig. 9. Levels of reduced glutathione (GSH) in hemolysates preparedFig. 7. Increasing MDA  levels in hemolysates prepared before and after
treatment with increasing concentrations of ZnO and TiO2 nanoparticles
and their ionic forms. Data represent mean ± S.D. (n = 3), p-value ≤0.05.
control (p-value ≤ 0.05), and TiO2 NPs showed an increase
upto 74% in SOD activity. A rise of around 84% in CAT level
was observed at 500 ppm concentration of ZnO nanopar-
ticles. Exposure with the same concentration of TiO2 NPs
showed an increase by 80% in CAT activity with respect to
untreated control.
The effects of increasing concentrations of ZnO and TiO2
NPs along with their ionic forms on the extent of LPO, mea-
sured in terms of MDA  level are shown in Fig. 7. A signiﬁcant
elevation in malondialdehyde (MDA) levels of nanoparti-
cle treated erythrocytes was recorded. At 500 ppm, ZnO
NPs showed 85% increase in activity, and TiO2 nanopar-
ticles showed around 83% rise compared with the negative
control (p-value ≤ 0.05).
Fig. 8 gives the trend of GST activity in hemolysates
exposed to different concentrations of test samples. There
was a decline in GST activity with increasing concentra-
tions of the test samples which were statistically signiﬁcant
at 250 ppm and 500 ppm concentrations only. It was
decreased up to 79% compared with control in case of ZnO
NPs and 70% in case of TiO2 NPs.
The pattern of change in activity proﬁle of GSH in the
hemolysates after treatment with different concentrations
of ZnO and TiO2 NPs is depicted in Fig. 9. The increasing
concentrations of both the NPs had only diminutive effect
on GSH level. Both ZnO NPs and TiO2 NPs induced a dose-
dependent and roughly equal decline in GSH concentration.
Fig. 8. Declining activity of GST in hemolysates prepared before and after
incubation with increasing concentrations of ZnO and TiO2 nanoparti-
cles and their respective ions. Data represent mean ± S.D. (n = 3), p-value
≤0.05.before and after exposure increasing concentrations of ZnO and TiO2
nanoparticles as well as their ionic counterparts. Data represent
mean ± S.D. (n = 3), p-value ≤0.05.
ZnO NPs at 500 ppm concentration, the levels decreased by
33% and TiO2 NPs at same concentration decreased the GSH
level with respect to control by 30%.
3.2.3. In vitro ROS generation
Fig. 10 shows the proﬁles of in vitro ROS generation
proﬁles by both ZnO and TiO2 NPs and their ionic forms.
Both nanoparticles were found to generate all the three ROS
namely superoxide radicals, hydroxyl radicals and hydro-
gen peroxide. However, ZnO nanoparticles showed a higher
generation of ROS compared with TiO2 NPs. Interestingly,
the ionic forms of both NPs here showed a signiﬁcantly
lesser degree of ROS generation (p-value ≤ 0.05).
3.2.4. Comet assay
The tail lengths (parameter of DNA damage) are plot-
ted with increasing concentrations of ZnO and TiO2 NPs
as well as their ionic forms in Fig. 11. The ﬁgures depict a
dose-dependent DNA damage in terms of tail length in all
the four cases. At 500 ppm, the ZnO NPs showed 13% more
DNA damage to human lymphocyte indicating thereby a
higher genotoxic potential of ZnO NPs compared to TiO2
NPs though not a signiﬁcant one.
4. Discussion
Owing to the growing applications of metal oxide NPs
in various household products and industry, their release
into the environment may  pose serious threats to ecologi-
cal systems and human health [37–40]. Some investigators
have worked on the toxic effects of nanoparticles on var-
ious organs and systems [41–43]. Nevertheless, there is
a general lack of information concerning the effects of
manufactured nanomaterials on humans, especially the
studies on the toxic effects of nanoparticles are in pre-
liminary stages and nothing is known about their mode of
action, target sites and effectiveness [44]. Since most of the
future applications of therapeutic nanoparticles are based
on intravenous or oral administration, their interaction
with human blood components is of extreme importance.
We have used human erythrocytes as well as lymphocytes
in our in vitro studies to assess the adverse effects caused
by ZnO and TiO2 NPs.
M. Khan et al. / Toxicology Repo
(a)
(b)
(c)
Fig. 10. Typical patterns of in vitro generation of different ROS i.e. (a)
superoxide radicals (b) hydroxyl radicals, and (c) hydrogen peroxide by
ZnO and TiO2 nanoparticles and their respective ions. In all the three
graphs, the nanoforms of ZnO and TiO2 exhibited a greater release of
ROS as compared to their respective ionic counterparts. Data represent
mean ± S.D. (n = 3), p-value ≤0.05.
Fig. 11. Increasing DNA damage in human lymphocytes measured in
terms of tail length after exposure to different concentrations of ZnO and
TiO2 nanoparticles and their respective ions. Signiﬁcant increase in tail
length was observed at 100, 250 and 500 ppm with respect to control. ZnO
NPs showed signiﬁcant DNA damage at 500 ppm as compared to TiO2 NPs
Data represent mean ± S.D. (n = 3), p-value ≤0.05.rts 2 (2015) 765–774 771
Present study deals with the comparative analysis of the
cytotoxicity and genotoxicity of the ZnO and TiO2 NPs along
with their respective ionic forms. To assess the toxicity of
NPs at the cellular level, hemolysis assay was  performed.
The rationale for this assay was to evaluate the mechani-
cal damage by NPs vis-à-vis respective ionic forms on the
RBC’S membrane. Moreover, human blood is the ultimate
target of these NPs in the human body. A concentration
dependent hemolytic activity was recorded for both the
NPs as well as their ionic forms. ZnO NPs were found to
show a signiﬁcantly higher hemolytic activity as compared
to TiO2 NPs at all experimental treatments. However, both
the nanoforms did not show any signiﬁcant difference in
cytotoxicity when compared to their respective ions. Abott
et al. [45] also reported a higher cytotoxicity of ZnO NPs
on Caco-2 and SW480 human intestinal epithelial cells as
compared to TiO2 NPs. Dose dependent cytotoxicity of TiO2
NPs was also recorded by Li et al. [46].
Oxidative stress is said to be the main mechanism of
nanoparticle toxicity [4–6]. In the present study, both ZnO
and TiO2 NPs seem to have triggered oxidative stress in
human erythrocytes which is evident from the typical
changes in SOD, CAT and GST as well as in the levels of
glutathione (GSH) and MDA  (Figs. 5–9).
In our study, both SOD and CAT levels showed a dose
dependent increase in their activity. There was a signif-
icant rise in SOD and CAT levels with respect to control
(p-value ≤ 0.05) by both the NPs as well as their ionic forms
at higher concentrations of 250 ppm and 500 ppm only
(Figs. 5 and 6). SOD activity proﬁle suggests that ionic forms
of ZnO were found to be signiﬁcantly less toxic than its
nanoform at 250 and 500 ppm concentrations while in case
of TiO2, no signiﬁcant difference was found between the
nano and the ionic forms. Looking at the CAT activity proﬁle,
both the NPs have shown a signiﬁcantly higher response
(increase in CAT activity) compared to ionic forms at higher
doses. Rise in SOD and CAT activities was  also recorded in
cells of Oreochromis mossambicus and mouse liver exposed
to ZnO NPs respectively [47,48] which are consistent with
our results.
LPO can be deﬁned as the oxidative deterioration of
cell membrane lipids and has been used extensively as
a marker of oxidative stress [49]. LPO is estimated by
measuring the content of MDA. The over-accumulation
of MDA  can damage cells and trigger apoptosis [50]. Our
study showed a continuous rise in MDA  activity up to the
maximum experimental concentration. Moreover, both the
nanoforms displayed a higher response toward MDA  activ-
ity compared with their ionic forms although the change
is not signiﬁcant (p-value ≤ 0.05; Fig. 7). According to the
graph, there was  an insigniﬁcant difference between ZnO
and TiO2 NPs in response to MDA  levels. Meena et al.
[51] also reported an increase in MDA  levels in HEK cells
exposed to TiO2 nanoparticles.
There was  a gradual decrease in the GST activity as
a result of increasing concentrations of both the test
nanoparticles and their ionic forms (Fig. 8). The decrease
was signiﬁcant only at 250 ppm and 500 ppm concen-
trations for all the samples. Also, when both the NPs
were compared with their ionic counterparts, they were
found to signiﬁcantly differ in their response toward GST
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activity at higher concentrations i.e. at 250 and 500 ppm
only. Both exhibited roughly equal degree of change in
GST activity at 50 and 100 ppm concentrations. Decrease
in GST levels by the exposure of ZnO NPs and Zn2+
ions to ﬁsh cells was reported by Fernandez et al. [52].
Our ﬁndings are consistent with their results in terms
of higher cytotoxicity of ZnO NPs than those of Zn2+
ions.
Another marker of response to oxidative stress that
we monitored in the present study was the change in
the intracellular GSH levels, which has been often shown
to be involved in cellular responses to toxins and xeno-
biotics [53]. GSH levels are supposed to be suppressed
under severe oxidative stress due to loss of compensatory
responses and oxidative conversion of GSH to its oxidized
form [54]. Our results indicated a slight decline in GSH
levels in the hemolysates treated with all the four sam-
ples with respect to untreated control but not statistically
signiﬁcant one among the two NPs and their ionic forms
(Fig. 9). GSH levels have been reported to be decreased
signiﬁcantly after oral administration of ZnO NPs in lung
tissue [55]. In the present study, the ZnO NPs showed an
insigniﬁcant difference in GSH activity compared to their
ionic forms. However, the TiO2 NPs exhibited signiﬁcantly
greater decline in the GSH activity in comparison to their
ionic forms only at higher concentrations.
These nanoparticles have been found to generate reac-
tive oxygen species in living system as reported by recent
studies [56–58]. However, our study is the ﬁrst to demon-
strate the in vitro generation of ROS by nanoparticles
in a dose dependent manner (Fig. 10). ZnO nanoparti-
cles showed a higher generation of all the three species
i.e. superoxide radicals, hydroxyl radicals and hydro-
gen peroxide compared to TiO2 NPs. Moreover, both the
nanoforms showed a signiﬁcantly greater ROS generation
compared to the ionic forms of ZnO and TiO2 (p-value
≤ 0.05).
Genotoxicity of ZnO and TiO2 nanoparticles was  also
evaluated by in vitro comet assay in human lymphocytes. As
evident from the ﬁgure (Fig. 11), ZnO NPs induced a higher
DNA damage to human lymphocyte compared with TiO2
NPs. Furthermore, at 500 ppm concentration, both ZnO and
TiO2 NPs have shown a signiﬁcant increase in tail length as
compared to their ionic forms with p-value ≤0.05. These
results are in conformity with our results of hemolysis,
antioxidant enzymes and ROS generation. A recent report
by Demir et al. [59] also afﬁrms the genotoxic potential
of zinc oxide (ZnO, ≤35 and 50 nm)  and titanium dioxide
(TiO2, 21 and 50 nm)  nanoparticles in the nuclei of Allium
cepa root meristem cells by using a modiﬁed alkaline comet
assay. The authors had taken three different concentrations
i.e. 10, 100 and 1000 g/ml and their results indicated that
ZnO showed genotoxicity at 100 and 1000 g/ml concen-
trations while TiO2 NPs exhibited DNA damage only at the
highest concentration inferring that ZnO is more genotoxic
compared to TiO2 NPs. Musarrat et al. [60] had also reported
dose dependent genotoxic effect of ZnO NPs in human lym-
phocytes by the use of alkaline comet assay. Their results
showed an increase in tail length with increasing concen-
trations of ZnO NPs again indicating the toxic nature of ZnO
NPs.orts 2 (2015) 765–774
5. Conclusions
Although we have demonstrated the in vitro generation
of ROS directly for the ﬁrst time, the genotoxicity and cyto-
toxicity assay conducted on the ZnO and TiO2 NPs were also
suggesting the role of ROS in the test NPs mediated toxic-
ity. This study is also the ﬁrst to examine the comparative
hemolytic activities of ZnO and TiO2 NPs. ROS generation
has also shown to induce hemolysis [61]. Therefore, we can
afﬁrm that ROS generation is the main mechanism to cause
various types of toxicities by ZnO and TiO2 nanoparticles.
Present results clearly suggest that both zinc oxide and
titanium dioxide in nanoform are signiﬁcantly cytotoxic
as well as genotoxic at all concentrations with respect to
untreated sample or control. However, comparing with
the ionic forms, no signiﬁcant difference was  obtained.
Moreover, the ZnO NPs were found to exhibit signiﬁ-
cantly greater toxicity at higher concentrations compared
to those of TiO2 in terms of cytotoxic and genotoxic effects.
The above mentioned toxicological tests and the result-
ing database would provide information for material safety
data sheets for NPs as well as a basis for their risk assess-
ments and risk management. However, the actual and
precise conclusion can only be drawn after more inten-
sive experimental works are carried out by using the whole
animal or the cell lines for such studies.
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